OakChart

Revvity Inc

RVTYHealthcare·Diagnostics & Research·USA·Large·NYSE·Nov 13 • 4:27 AM ET

157.88+0.86 (0.55%)
2026-11-13 13:07 CET
Market cap
$17.63B
Revenue, TTM
2,941.76 USD m
Net income, TTM
253.42 USD m
Free cash flow, TTM
590.47 USD m
EPS diluted, TTM
2.26
Price / earnings
69.98
Compare

Price

RVTY against its 20, 50 and 200-day averages
Terms2050200Miss
Patternshover a marker to name it
RS 100Sales 759Price750759100.00120.00140.00160.002.2M4.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26RVTYclose 157.8820-day 158.1750-day 150.47200-day 114.05157.8852w high 171.7452-week range, not 6 months

8.1% under the 52-week high of 171.74 on 3 Nov 2026. 52-week low 81.22 on 29 Apr 2026. Last 15 sessions, 15.0% high to low

Volume 0.01× normal · the line is the 50-bar volume average

Setup. RS line 100
CANSLIM 5 of 6 — fails: EPS Growth This Year: High (>25%)
VCP 5 of 6 — fails: Average True Range: Under 2
Minervini 4 of 4
Zanger 2 of 5 — fails: Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 5 of 5
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 1 of 4 — fails: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); P/E: Under 25
Value 0 of 4 — fails: P/E: Under 15; P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 1 of 4 — fails: Dividend Yield: Over 2%; Dividend Growth: Growing 2+ Years; P/E: Under 25
Small Cap 3 of 4 — fails: Float: Under 100M
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 2 of 3 — fails: Performance: Year +100%

Profile

RVTY
52-week range, 85% of the way up
81.22171.74

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.

IndexS&P 500, RUI
Employees11000
IPOJul 06, 1965
Beta1.09
ATR, 14d6.89
Rel volume0.01
Short float5.87%
Insider own0.47%
Inst own105.13%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap$17.63B
Enterprise Value19.80B
Income253.42M
Sales2.94B
Book / share65.14
Cash / share5.32
Dividend Est.0.28 (0.18%)
Dividend TTM0.28 (0.18%)
Dividend Ex-DateJan 22, 2027
Dividend Gr. 3/5Y0.00% 0.00%
Payout13.49%
Employees11000
IPOJul 06, 1965

Ratios

Price / earnings69.98
Forward price / earnings26.49
Price / earnings / growth2.97
Price / sales5.99
Price / book2.42
Price / cash29.70
Price / free cash flow29.85
Value / cash profit22.08
Value / sales6.73
Quick Ratio2.10
Current Ratio2.65
Debt / equity0.38
Long-term debt / equity0.38
Options and shortYes / Yes

Earnings

Earnings / share2.26
Earnings next year5.96
Earnings next quarter1.61
Earnings this year7.20%
Earnings next year9.86%
Earnings growth, 5 years8.92%
Past earnings growth-22.75% -20.40%
Past sales growth-4.82% -5.47%
Earnings vs last year13.22%
Sales vs last year4.56%
Earnings vs last quarter37.01%
Sales vs last quarter4.29%
EarningsNov 03 BMO
Surprise6.42% 2.14%

Ownership

Insiders own0.47%
Insider trades-1.71%
Institutions own105.13%
Institution trades4.64%
Return on assets2.14%
Return on equity3.45%
Return on capital2.53%
Gross Margin49.15%
Operating margin16.44%
Profit Margin8.61%
20-day average-0.19%
50-day average4.93%
200-day average38.43%

Technical

Shares out111.62M
Shares floating111.11M
Short / float5.87%
Short ratio3.42
Short interest6.53M
52-week high171.74 -8.1%
52-week low81.22 +94.4%
Volatility4.42% 4.45%
Average range6.89
Strength index52.66
Market sensitivity1.09
Relative volume0.01
Avg Volume1.91M
Volume1,071

Performance

Perf Week1.79%
Perf Month2.05%
Perf Quarter35.90%
Perf Half Y68.01%
Perf YTD63.18%
Perf Year69.04%
Perf 3Y87.91%
Perf 5Y-14.00%
Perf 10Y210.18%
Recommendation2.55
Target Price174.57
Prev Close157.02
Price157.88
Change %0.55%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 04, 2026UpgradeCFRAHold → Buy
Oct 06, 2026InitiatedWilliam BlairOutperform
Sep 09, 2026ResumedUBSNeutral$140-11.3%
Sep 01, 2026InitiatedRBC Capital MktsSector Perform$135-14.5%
Jun 26, 2026ResumedBernsteinMkt Perform$115-27.2%
Jun 02, 2026ResumedWolfe ResearchPeer Perform
Apr 14, 2026DowngradeBarclaysOverweight → Equal Weight$95-39.8%
Dec 15, 2025DowngradeBofA SecuritiesBuy → Neutral$110-30.3%
Dec 09, 2025InitiatedGoldmanNeutral$105-33.5%
Oct 16, 2025InitiatedGuggenheimNeutral

Peers

Mkt cap
TickerCompanyMkt cap
DHRDanaher Corp163.13B
AAgilent Technologies Inc48.88B
QGENQiagen NV10.35B
TMOThermo Fisher Scientific Inc259.15B
BIOBio-Rad Laboratories Inc10.00B
WATWaters Corp45.43B
MTDMettler-Toledo International Inc34.43B
TECHBio-Techne Corp11.44B
ILMNIllumina Inc31.53B
BRKRBruker Corp9.21B

Insider trading

latest 14 of 24
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Gonzales AnitaVP and CAOOct 01 '26Sale155.488413,0607,117Oct 02 04:05 PM
Gonzales AnitaOfficerOct 01 '26Proposed Sale155.488413,060Oct 01 10:48 AM
Krakowiak MaxwellPlease See RemarksSep 21 '26Sale144.531,631235,72814,781Sep 23 04:05 PM
Krakowiak MaxwellOfficerSep 21 '26Proposed Sale144.531,631235,728Sep 21 10:49 AM
Vohra Tajinder SPlease See RemarksSep 16 '26Sale140.887,3301,032,6506,635Sep 18 04:05 PM
Vohra Tajinder SOfficerSep 16 '26Proposed Sale140.887,3301,032,650Sep 16 09:55 AM
Gonzales AnitaVice President and CAOJul 20 '26Sale109.48859,3067,201Jul 22 04:05 PM
Gonzales AnitaOfficerJul 20 '26Proposed Sale109.48859,306Jul 20 09:40 AM
Gonzales AnitaVice President and CAOApr 20 '26Sale92.80807,4247,319Apr 22 04:05 PM
Gonzales AnitaOfficerApr 20 '26Proposed Sale92.80807,424Apr 20 09:55 AM
Victor MiriamePlease See RemarksFeb 24 '26Option Exercise95.741,862178,26819,984Feb 26 04:05 PM
Victor MiriamePlease See RemarksFeb 24 '26Sale97.131,862180,85618,122Feb 26 04:05 PM
McMurry-Heath MichelleDirectorFeb 23 '26Sale97.2660058,3564,233Feb 25 04:05 PM
Victor MiriameOfficerFeb 24 '26Proposed Sale97.131,862180,856Feb 24 11:21 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
VOOVanguard S&P 500 ETFAUM: 1070.75B
VBVanguard Morningstar Small-Cap ETFAUM: 80.23B
RSPInvesco S&P 500 Equal Weight ETFAUM: 105.70B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.88B
IVViShares Core S&P 500 ETFAUM: 882.14B
SPYSPDR S&P 500 ETF TrustAUM: 805.69B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.51B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.54B
TCAFT. Rowe Price Capital Appreciation Equity ETFAUM: 8.35B

News

latest 14 of 200

Quarterly earnings

2026Q3 EPS 1.380 beat 1.297, from 1.180 a year earlier. Sales 709.61 beat 694.73, from 698.95 a year earlier
EPS
1.70002024Q4 EPS 1.420 against 1.36824Q42025Q1 EPS 1.010 against 0.94925Q12025Q2 EPS 1.180 against 1.14825Q22025Q3 EPS 1.180 against 1.14125Q32025Q4 EPS 1.700 against 1.57025Q42026Q1 EPS 1.040 against 1.01626Q12026Q2 EPS 1.410 against 1.21426Q22026Q3 EPS 1.380 against 1.29726Q3
Sales, USD millions
772.0602024Q4 sales 729.58 against 727.9124Q42025Q1 sales 665 against 66125Q12025Q2 sales 720.28 against 710.7625Q22025Q3 sales 698.95 against 699.3625Q32025Q4 sales 772.06 against 764.9425Q42026Q1 sales 711.12 against 704.0726Q12026Q2 sales 711 against 702.9626Q22026Q3 sales 709.61 against 694.7326Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-11-03 08:301.3801.2970.560709.61694.73EPS +6.4% · sales +2.1%vs 2025Q3, year-ago quarter · EPS +16.9% · sales +1.5%17 EPS · 15 salesOpen +7.53% vs SPY +0.08%. Close +7.84% vs SPY +0.30%
2026Q2ended 2026-06-302026-08-04 08:301.4101.2140.464711702.96EPS +16.2% · sales +1.1%vs 2025Q2, year-ago quarter · EPS +19.5% · sales -1.3%11 EPS · 12 salesOpen -0.62% vs SPY +0.39%. Close -3.32% vs SPY +1.80%
2026Q1ended 2026-03-312026-05-05 08:301.0401.0160.364711.12704.07EPS +2.3% · sales +1.0%vs 2025Q1, year-ago quarter · EPS +3.0% · sales +6.9%16 EPS · 14 salesOpen +3.06% vs SPY +0.52%. Close +6.69% vs SPY +0.80%
2025Q4ended 2025-12-312026-02-02 08:301.7001.5700.871772.06764.94EPS +8.3% · sales +0.9%vs 2024Q4, year-ago quarter · EPS +19.7% · sales +5.8%18 EPS · 16 salesOpen -3.95% vs SPY -0.35%. Close -1.57% vs SPY +0.50%
2025Q3ended 2025-09-302025-10-27 08:301.1801.1410.407698.95699.36EPS +3.4% · sales -0.1%vs 2024Q3, year-ago quarter · EPS -7.8% · sales +2.1%18 EPS · 16 salesOpen -4.08% vs SPY +0.81%. Close -1.75% vs SPY +1.18%
2025Q2ended 2025-06-302025-07-28 08:301.1801.1480.468720.28710.76EPS +2.8% · sales +1.3%vs 2024Q2, year-ago quarter · EPS -3.3% · sales +4.1%18 EPS · 16 salesOpen -9.40% vs SPY +0.06%. Close -8.32% vs SPY -0.03%
2025Q1ended 2025-03-312025-04-28 08:301.0100.9490.345665661EPS +6.5% · sales +0.6%vs 2024Q1, year-ago quarter · EPS +3.1% · sales +2.3%19 EPS · 17 salesOpen +7.36% vs SPY +0.14%. Close +0.82% vs SPY +0.04%
2024Q4ended 2024-12-312025-01-31 08:301.4201.3680.780729.58727.91EPS +3.8% · sales +0.2%vs 2023Q4, year-ago quarter · EPS +13.6% · sales +4.8%19 EPS · 17 salesOpen -1.08% vs SPY +0.41%. Close -0.56% vs SPY -0.53%
2024Q3ended 2024-09-302024-11-04 08:301.2801.1260.764684.25679.66EPS +13.6% · sales +0.7%vs 2023Q3, year-ago quarter · EPS +8.5% · sales +2.0%19 EPS · 17 salesOpen +1.24% vs SPY +0.02%. Close +3.12% vs SPY -0.22%
2024Q2ended 2024-06-302024-07-29 08:301.2201.1220.641691.89690.33EPS +8.7% · sales +0.2%vs 2023Q2, year-ago quarter · EPS +0.8% · sales -2.5%18 EPS · 16 salesOpen +5.46% vs SPY +0.29%. Close +9.07% vs SPY +0.06%
2024Q1ended 2024-03-312024-04-29 08:300.9800.9430.224650.13647.25EPS +4.0% · sales +0.4%vs 2023Q1, year-ago quarter · EPS -3.0% · sales -3.7%16 EPS · 14 salesOpen +1.89% vs SPY +0.36%. Close +3.46% vs SPY +0.35%
2023Q4ended 2023-12-312024-02-01 08:301.2501.1650.832696.11677.13EPS +7.3% · sales +2.8%vs 2022Q4, year-ago quarter · EPS -26.5% · sales -6.1%17 EPS · 15 salesOpen +1.23% vs SPY +0.36%. Close +1.94% vs SPY +1.31%
2023Q3ended 2023-09-302023-10-30 08:301.1801.1940.077670.95695.4EPS -1.1% · sales -3.5%vs 2022Q3, year-ago quarter · EPS -21.9% · sales -35.0%15 EPS · 12 sales-
2023Q2ended 2023-06-302023-08-01 08:301.2101.1890.284709.27708.38EPS +1.8% · sales +0.1%vs 2022Q2, year-ago quarter · EPS -47.8% · sales -42.3%16 EPS · 13 sales-
2023Q1ended 2023-03-312023-05-11 08:301.0100.9994.503675.07678.9EPS +1.1% · sales -0.6%vs 2022Q1, year-ago quarter · EPS -58.1% · sales -46.4%14 EPS · 11 sales-
2022Q4ended 2022-12-312023-02-14 08:301.7001.6391.088741.421,029EPS +3.7% · sales -27.9%vs 2021Q4, year-ago quarter · EPS -33.6% · sales -45.7%11 EPS · 9 sales-

Annual earnings

2025FY EPS 5.060 beat 4.937, from 4.900 a year earlier. Sales 2,856 beat 2,848, from 2,756 a year earlier
EPS
11.36002018FY EPS 3.610 against 3.60520182019FY EPS 4.100 against 4.07420192020FY EPS 8.300 against 7.36020202021FY EPS 11.360 against 11.03820212022FY EPS 7.950 against 7.78420222023FY EPS 4.650 against 4.56020232024FY EPS 4.900 against 4.84720242025FY EPS 5.060 against 4.9372025
Sales, USD millions
5,07002018FY sales 2,779 against 2,77020182019FY sales 2,884 against 2,88120192020FY sales 3,784 against 3,65420202021FY sales 5,070 against 4,97620212022FY sales 3,313 against 4,58920222023FY sales 2,751 against 2,73220232024FY sales 2,756 against 2,75420242025FY sales 2,856 against 2,8482025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate-7.793--3,58020.26
2029FYestimate-7.075--3,36422.32
2028FYestimate-6.538--3,19324.15
2027FYestimate-5.960--3,03026.49
2026FYestimate-5.425--2,86629.10
2025FY5.0604.9372.0702,8562,84819.12
2024FY4.9004.8472.4092,7562,75422.78
2023FY4.6504.560-0.9492,7512,73223.51
2022FY7.9507.7844.5023,3134,58917.64
2021FY11.36011.0388.0845,0704,97617.70
2020FY8.3007.3606.4953,7843,65417.29
2019FY4.1004.0742.0412,8842,88123.68
2018FY3.6103.6052.1412,7792,77021.76
2017FY2.9002.8931.0202,2572,23425.21
2016FY2.6002.7562.1182,1162,26420.06
2015FY2.5502.5741.8752,2622,27261.91
2014FY2.4702.3951.3902,2372,23363.92
2013FY2.0902.0561.4602,1662,16875.54
2012FY2.0602.0650.6002,1422,14176.64
2011FY1.8301.6790.0601,9521,93486.27
2010FY1.3301.3321.1501,7041,726118.71

Quarterly results

2026Q3 revenue 728.9, from 698.95 a year earlier. Operating margin 17.1%, from 13.0% a year earlier
Revenue, USD millions
772.0602024Q4 revenue 729.3724Q42025Q1 revenue 664.7625Q12025Q2 revenue 720.2825Q22025Q3 revenue 698.9525Q32025Q4 revenue 772.0625Q42026Q1 revenue 711.1226Q12026Q2 revenue 729.6926Q22026Q3 revenue 728.926Q3
Operating margin
18.902024Q4 operating margin 18.1%24Q42025Q1 operating margin 13.2%25Q12025Q2 operating margin 14.5%25Q22025Q3 operating margin 13.0%25Q32025Q4 operating margin 18.9%25Q42026Q1 operating margin 12.3%26Q12026Q2 operating margin 17.3%26Q22026Q3 operating margin 17.1%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E 5.42 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-045.42+0.0%
2026Q4Eper share2026-11-041.61-0.2%
2026FYRper share2026-11-032.45+2.1%
2026Q4Rper share2026-11-030.89-1.1%
2026FYSUSD millions2026-11-032,866+0.5%
2026Q4S-2026-11-03759.13-0.1%
2026Q3Eper share2026-10-261.30+0.1%
2026Q3Rper share2026-10-180.580.0%
2026Q3S-2026-10-18694.730.0%
2026Q2Eper share2026-07-311.21+0.4%
2026Q2S-2026-07-21702.960.0%
2026Q2Rper share2026-07-190.610.0%
2026Q1Eper share2026-05-011.02-0.1%
2026Q1S-2026-05-01704.20.0%
2026Q1Rper share2026-04-180.360.0%
2025FYEper share2026-01-304.940.0%
2025Q4Eper share2026-01-221.57+0.4%
2025FYRper share2026-01-222.06+0.8%
2025Q4Rper share2026-01-220.86+2.6%
2025FYSUSD millions2026-01-222,847+0.0%
2025Q4S-2026-01-22764.35+0.1%
2025Q3Rper share2025-10-230.50-0.3%
2025Q3Eper share2025-10-221.14+0.0%
2025Q3S-2025-10-15699.360.0%
2025Q2Eper share2025-07-251.14+0.0%
2025Q2S-2025-07-15710.370.0%
2025Q2Rper share2025-07-120.540.0%
2025Q1Eper share2025-04-230.95-0.1%
2025Q1Rper share2025-04-160.330.0%
2025Q1S-2025-04-166610.0%
2024FYEper share2025-01-284.850.0%
2024Q4Eper share2025-01-281.370.0%
2024FYSUSD millions2025-01-282,7540.0%
2024Q4S-2025-01-28727.910.0%
2024Q4Rper share2025-01-270.75+0.3%
2024FYRper share2025-01-242.18+0.1%
2024Q3Eper share2024-10-291.13+0.1%
2024Q3S-2024-10-16679.660.0%
2024Q3Rper share2024-10-120.500.0%
2024Q2Eper share2024-07-211.120.0%
2024Q2S-2024-07-21690.330.0%
2024Q2Rper share2024-07-130.450.0%
2024Q1Eper share2024-04-270.940.0%
2024Q1S-2024-04-26647.25+0.1%
2024Q1Rper share2024-04-160.290.0%
2023FYEper share2024-01-294.56+0.1%
2023FYSUSD millions2024-01-292,732+0.0%
2023FYRper share2024-01-135.220.0%

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share1.022.1412.0416.4958.0844.502-0.9492.4092.0762.256-
Sales USD millions2,2572,7782,8843,7833,8283,3122,7512,7552,8562,942-
Shares million shares110111111112126126123121112-112
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share0.7640.780.3450.4680.4070.8710.3640.4640.557
Sales USD millions684729665720699772711730729
Shares million shares122121119116114112112112112

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue2,941.762,856.05+3.7%2,755.03+0.2%2,750.57-16.9%3,311.82-13.5%3,827.81+1.2%3,782.74+31.2%2,883.67+3.8%2,778.00
Cost of Goods Sold Incl. D&A1,495.901,486.19+3.8%1,432.37+0.3%1,428.38-7.9%1,551.09+0.3%1,545.85-13.7%1,792.23+12.7%1,590.62+4.2%1,526.76
Gross Profit1,445.861,369.87+3.6%1,322.66+0.0%1,322.19-24.9%1,760.73-22.8%2,281.95+14.6%1,990.51+53.9%1,293.06+3.3%1,251.24
Selling, General and Administrative Excl. Other962.37942.06+3.3%912.14-1.1%922.70-5.8%979.61+4.0%941.95-3.0%970.72+9.4%887.57+0.8%880.27
Research and Development213.15215.84+9.7%196.84-9.1%216.58-2.3%221.62+10.6%200.34-2.5%205.39+8.5%189.34+1.7%186.10
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income483.49427.81+4.2%410.52+2.8%399.49-48.9%781.12-41.7%1,340.01+31.4%1,019.79+151.5%405.48+9.3%370.97
Interest Expense92.0392.19-4.2%96.28-2.6%98.81-4.9%103.95+1.8%102.13+105.5%49.71-21.9%63.63-5.0%66.98
Unusual Expense127.1982.63+48.0%55.82-58.0%132.85+145.2%54.18-23.2%70.56+110.6%33.51-53.0%71.25+21.2%58.78
Net Income Before Taxes282.77268.28-15.1%316.13+72.8%182.98-71.9%651.84-45.8%1,203.58+32.8%906.36+282.2%237.14-8.0%257.68
Income Taxes30.0028.39-14.1%33.05+852.4%3.47-97.5%139.16-55.7%314.15+76.2%178.27+1798.5%9.39-53.5%20.21
Consolidated Net Income252.77239.88-15.3%283.07+57.7%179.50-65.0%512.68-42.4%889.44+22.2%728.10+219.7%227.75-4.1%237.47
Net Income From Continuing Operations252.77239.88-15.3%283.07+57.7%179.50-65.0%512.68-42.4%889.44+22.2%728.10+219.7%227.75-4.1%237.47
Net Income253.42242.02-18.2%295.83-118.38-120.8%569.18-39.7%943.16+29.5%728.10+220.0%227.56-4.7%238.79
EPS (Recurring) per share3.062.57-5.9%2.73-0.20-104.2%4.80-43.6%8.51+27.0%6.70+169.1%2.49-0.8%2.51
EPS (Basic, Before Extraordinaries) per share2.262.08-13.7%2.41-0.95-121.1%4.51-44.5%8.12+24.3%6.53+218.5%2.05-5.1%2.16
EPS (Diluted) per share2.262.08-13.7%2.41-0.95-121.1%4.50-44.3%8.08+24.5%6.49+218.1%2.04-4.7%2.14
EBITDA896.58833.15-0.6%838.37+0.9%831.26-31.2%1,208.12-26.8%1,651.45+30.4%1,266.30+104.4%619.51+12.3%551.56
Non-Operating Income (Expense)18.5115.28-73.5%57.70+280.9%15.15-47.5%28.85-20.5%36.27-30.20-33.46-368.3%12.47
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense19.4017.55-41.1%29.81-3.2%30.81-20.4%38.72+180.4%13.81+15.8%11.93-40.1%19.91+31.2%15.17
Price To Earnings Ratio ratio statement ratio, not the snapshot69.6069.6045.3518.3729.3524.8722.1447.5936.71
Price To Sales Ratio ratio5.763.954.994.965.356.134.253.753.10
Gross Margin %49.1547.9648.0148.0753.1659.6252.6244.8445.04
Operating Margin %16.4414.9814.9014.5223.5935.0126.9614.0613.35
Net Margin %8.618.4710.74-4.3017.1924.6419.257.898.60
Shares Outstanding million shares111.62112.28-6.9%120.65-2.3%123.43-2.3%126.30+0.0%126.24+12.6%112.09+0.9%111.14+0.5%110.60
Market Capitalization17,529.5617,529.56+29.1%13,583.16+0.7%13,489.62-23.8%17,712.03-30.2%25,373.77+57.9%16,068.27+48.9%10,787.91+23.5%8,737.82

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue728.90+4.3%729.69+1.3%711.12+7.0%772.06+5.9%698.95+2.2%720.28+4.1%664.76+2.3%729.37+4.8%
Cost of Goods Sold Incl. D&A360.42-3.4%362.92-3.6%373.56+10.7%399.00+7.9%373.05+24.7%376.51+23.0%337.52+14.5%369.68-8.1%
Gross Profit368.48+13.1%366.77+6.7%337.56+3.2%373.06+3.7%325.90-15.3%343.77-10.8%327.25-7.8%359.69+22.4%
Selling, General and Administrative Excl. Other244.09+3.9%240.87+0.8%249.95+4.5%227.47+0.0%235.04-16.7%238.97-15.8%239.28-14.8%227.40+16.9%
Research and Development48.11-5.3%48.97-8.1%57.89+8.0%58.18+18.2%50.80+3.4%53.27+10.7%53.60+6.4%49.21-0.8%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income124.39+36.9%125.90+20.1%87.61-0.4%145.59+10.1%90.86-11.4%104.79+3.2%87.97+18.7%132.29+33.2%
Interest Expense20.81-8.6%22.99+0.2%24.72+7.7%23.51+3.2%22.77-6.6%22.94-7.2%22.96-5.9%22.78-7.3%
Unusual Expense27.62+103.5%41.83+161.6%15.93+25.7%41.81+113.9%13.5715.99+99.4%12.67-58.9%19.55-54.8%
Net Income Before Taxes77.68+39.5%63.53-7.5%49.99-4.6%91.56-3.2%55.69-44.5%68.65-20.8%52.38+51.6%94.56+201.3%
Income Taxes15.06+78.0%10.05-25.2%9.10-15.0%-4.21-168.2%8.46+21.4%13.43-4.5%10.71+83.1%6.17
Consolidated Net Income62.62+32.6%53.48-3.2%40.89-1.9%95.77+8.4%47.22-49.4%55.22-23.9%41.67+45.2%88.38+39.0%
Net Income From Continuing Operations62.62+32.6%53.48-3.2%40.89-1.9%95.77+8.4%47.22-49.4%55.22-23.9%41.67+45.2%88.38+39.0%
Net Income62.30+32.7%51.82-5.9%40.72-1.7%98.58+3.7%46.95-50.0%55.05-30.4%41.44+49.5%95.04-7.5%
EPS (Recurring) per share0.73+49.0%0.73+30.4%0.46+9.5%1.13+27.0%0.49-34.7%0.56-18.8%0.42+5.0%0.89-17.6%
EPS (Basic, Before Extraordinaries) per share0.56+36.6%0.46-2.1%0.36+5.9%0.88+12.8%0.41-46.8%0.47-26.6%0.34+54.5%0.78-6.0%
EPS (Diluted) per share0.56+36.6%0.46-2.1%0.36+5.9%0.87+11.5%0.41-46.1%0.47-26.6%0.34+54.5%0.78-6.0%
EBITDA227.31+17.8%227.94+9.8%192.66+3.9%248.67+4.8%192.92-8.3%207.57-0.6%185.39+1.9%237.32+15.8%
Non-Operating Income (Expense)1.73+49.1%2.46-11.5%3.03+7475.0%11.30+145.1%1.16-94.1%2.78-84.5%0.04-99.7%4.61
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.172.20+22.9%2.28+38.2%12.74-46.5%-1.79-8.2%1.65-18.3%23.81-8.6%
Price To Earnings Ratio ratio statement ratio, not the snapshot69.6052.7441.9148.3837.1938.2443.9245.35
Price To Sales Ratio ratio5.764.363.433.843.454.114.584.95
Gross Margin %50.5550.2647.4748.3246.6347.7349.2349.32
Operating Margin %17.0717.2512.3218.8613.0014.5513.2318.14
Net Margin %8.557.105.7312.776.727.646.2313.03
Shares Outstanding million shares111.62-2.1%111.58-4.1%111.63-6.5%112.28-6.9%114.03-6.6%116.33-5.7%119.41-3.3%120.65-2.3%
Market Capitalization17,529.56+72.3%12,412.17+8.9%9,795.06-22.9%10,969.13-19.2%10,173.80-35.4%11,400.39-11.9%12,711.55-2.0%13,583.16+0.7%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments919.87-21.0%1,164.45-27.4%1,604.29+252.3%455.40-24.6%604.34+50.1%402.61+109.8%191.89+17.6%163.11-19.3%202.13
Short Term Receivables744.67+17.8%632.40-0.1%632.81+3.3%612.78-13.4%707.94-38.7%1,155.11+59.3%725.18+14.6%632.67+14.6%552.30
Inventories379.50+3.2%367.59-14.1%428.06+5.6%405.46-4.8%425.89-17.2%514.57+44.2%356.94+5.5%338.35-3.8%351.68
Other Current Assets195.71+5.7%185.17-44.9%335.93-81.5%1,814.92+158.3%702.61+321.7%166.63+66.0%100.36-0.1%100.51+7.1%93.84
Total Current Assets2,239.75-4.7%2,349.61-21.7%3,001.09-8.7%3,288.56+34.7%2,440.78+9.0%2,238.92+62.9%1,374.38+11.3%1,234.63+2.9%1,199.95
Net Property, Plant & Equipment644.69-0.8%649.93-2.2%664.74-1.0%671.30+3.3%649.57+12.9%575.54+18.5%485.50+52.4%318.59+6.9%298.07
Total Investments and Advances93.13-3.8%96.78+13.7%85.10-23.0%110.58+36.6%80.98+3666.5%2.15-26.1%2.91+18.8%2.45+10.9%2.21
Long-Term Note Receivable38.01+35.0%28.16-4.8%29.59-13.1%34.04+13.6%29.96+33.1%22.51+14.4%19.68--
Intangible Assets8,960.50-1.6%9,104.54-4.7%9,555.87-3.1%9,858.94-5.6%10,448.97+117.1%4,812.81+9.5%4,394.51+5.8%4,152.27-4.5%4,349.14
Deferred Tax Assets32.65+482.0%5.61-31.3%8.16-56.0%18.530.0%18.53-71.7%65.52+9.2%60.00-24.3%79.31+17.9%67.28
Other Assets159.69+1.2%157.84-28.3%220.12+48.8%147.91-88.9%1,331.76+448.3%242.87+20.5%201.59+7.1%188.26+7.7%174.82
Total Assets12,168.41-1.8%12,392.48-8.6%13,564.67-4.0%14,129.85-5.8%15,000.55+88.4%7,960.31+21.7%6,538.56+9.4%5,975.52-1.9%6,091.46
Short Term Debt Incl. Current Port. of LT Debt618.86+2498.1%23.82-96.8%754.78+50.3%502.15+1396.7%33.55-92.0%421.28+805.0%46.55+213.3%14.86-93.2%217.31
Accounts Payable185.46+10.7%167.46-18.0%204.12-25.2%272.83-16.0%324.81-0.8%327.32+38.8%235.85+6.7%220.95-0.5%222.09
Income Tax Payable80.56+8.3%74.40-15.6%88.16+93.2%45.62-48.3%88.28-9.4%97.41+226.0%29.88-2.6%30.69+184.2%10.80
Other Current Liabilities446.35+15.2%387.41-4.0%403.40-44.3%723.89-5.6%767.10-4.8%806.18+78.9%450.55-10.8%505.14+0.9%500.70
Total Current Liabilities1,331.25+103.8%653.10-55.0%1,450.46-6.1%1,544.48+27.2%1,213.74-26.5%1,652.19+116.6%762.83-1.1%771.63-18.9%950.90
Long Term Debt2,779.34-15.8%3,301.98-0.3%3,310.52-19.1%4,093.32-20.2%5,127.13+185.1%1,798.10-18.7%2,210.44+17.8%1,876.62+4.9%1,788.80
Provision for Risks Charges0.000.000.000.000.000.00-100.0%0.80-42.9%1.40-39.1%2.30
Deferred Tax Liabilities487.25+6.8%456.10----224.94-1.1%227.33-28.3%316.93
Other Liabilities320.21+1.8%314.42-66.2%930.95-16.1%1,109.18-27.0%1,518.43+96.0%774.53+47.3%525.73+2.4%513.58-3.0%529.34
Total Liabilities4,918.05+4.1%4,725.60-17.0%5,691.93-15.6%6,746.98-14.2%7,859.31+86.0%4,224.82+13.4%3,724.74+9.9%3,390.57-5.5%3,588.28
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity7,250.36-5.4%7,666.87-2.6%7,872.74+6.6%7,382.88+3.4%7,141.24+91.2%3,735.49+32.8%2,813.82+8.9%2,584.95+3.3%2,503.19
Total Shareholders Equity7,250.36-5.4%7,666.87-2.6%7,872.74+6.6%7,382.88+3.4%7,141.24+91.2%3,735.49+32.8%2,813.82+8.9%2,584.95+3.3%2,503.19
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity7,250.36-5.4%7,666.87-2.6%7,872.74+6.6%7,382.88+3.4%7,141.24+91.2%3,735.49+32.8%2,813.82+8.9%2,584.95+3.3%2,503.19
Total Liabilities & Stockholders Equity12,168.41-1.8%12,392.48-8.6%13,564.67-4.0%14,129.85-5.8%15,000.55+88.4%7,960.31+21.7%6,538.56+9.4%5,975.52-1.9%6,091.46
Book Value Per Share per share64.57+1.6%63.55-0.4%63.79+9.1%58.46+3.3%56.57+69.7%33.33+31.6%25.32+8.3%23.37+3.0%22.68
Tangible Book Value Per Share per share-15.23-11.92-13.64-19.60-26.20-9.61-14.22-14.17-16.73
Full-Time Employees people11,0000.0%11,000-4.3%11,500-31.1%16,7000.0%16,700+19.3%14,000+7.7%13,000+4.0%12,500+13.6%11,000
Price to Book Ratio ratio2.411.721.752.503.554.313.843.363.18
Return on Assets %1.952.181.303.527.7510.043.643.943.03
Return on Equity %3.223.642.357.0616.3522.238.449.336.74
Return on Invested Capital %2.412.70-1.064.967.6913.164.535.352.63
Quick Ratio ratio1.403.031.771.871.661.041.331.160.89
Current Ratio ratio1.683.602.072.132.011.361.801.601.26

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income253.20241.20-10.8%270.38-61.0%693.09+21.8%569.18-39.7%943.16+29.6%727.89+219.9%227.56-4.4%237.93
Depreciation413.09405.34-5.3%427.85-0.9%431.77+1.1%427.00+37.1%311.44+26.3%246.51+15.2%214.03+18.5%180.59
Other Funds (Non Cash)144.1292.18+82.2%50.60-518.58-1087.4%52.52-33.1%78.49+18.9%66.03-55.4%147.90+98.9%74.35
Funds from Operations748.93677.24+4.7%646.60+34.0%482.62-48.8%942.78-26.2%1,277.76+26.3%1,011.30+91.5%528.13+19.5%441.77
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-93.10-96.78-18.30-391.35-262.97-297.7%132.99-119.12-164.66-130.73
Cash from Operating Activities655.84580.46-7.6%628.30+588.4%91.27-86.6%679.81-51.8%1,410.75+58.1%892.18+145.5%363.47+16.9%311.04
Capital Expenditures-65.36-73.52-86.65-1,302.98-85.63-86.02-77.51-81.33-93.25
Net Assets From Acquisitions-67.060.000.00-2.09-7.52-3,982.22-411.50-400.40-97.69
Sale of Fixed Assets and Businesses12.270.300.00-100.0%0.15-99.0%14.51+893.8%1.46-65.9%4.28+678.2%0.55-98.6%38.03
Purchase or Sale of Investments2.30-0.39-100.1%705.91-6.30-47.18-23.13-20.06-6.39-7.02
Purchase of Investments-5.20-0.39-6.59-6.30-47.18-23.13-20.06-6.39-7.02
Sale Or Maturity of Investments7.500.00-100.0%712.500.000.000.00-0.000.00
Other Uses0.030.000.000.00-15.91-22.960.000.000.00
Other Sources0.0056.25-64.1%156.90-94.0%2,624.73+29424.5%8.89+7981.8%0.11-60.7%0.280.00-100.0%0.07
Cash from Investing Activities-117.83-17.35-102.2%776.16-40.9%1,313.52-132.85-4,112.76-504.50-487.57-159.86
Cash Dividends Paid-31.42-32.80-34.45-34.97-35.34-32.37-31.21-31.06-31.01
Change in Capital Stock-260.65-817.89-361.88-384.54-66.52-47.95-256.0%30.73+129.0%13.42-32.61
Repurchase of Common Pref Stock-270.87-820.82-369.58-388.88-80.64-73.07-6.94-6.31-57.45
Sale of Common Pref Stock10.212.92-62.1%7.70+77.4%4.34-69.2%14.11-43.8%25.12-33.3%37.67+90.9%19.73-20.5%24.83
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-571.56-0.52-723.07-517.50-559.17-118.4%3,042.99-187.47-194.2%198.99-68.68
Change in Long Term Debt-571.56-0.52-723.07-517.50-559.17-118.4%3,042.99-187.47-194.2%198.99-68.68
Issuance of Long Term Debt25.000.000.00-100.0%6.31-97.4%240.00-95.2%4,955.39+593.4%714.70-70.7%2,436.73+99.1%1,223.71
Reduction of Long Term Debt-596.56-0.52-723.07-523.81-799.17-1,912.41-902.17-2,237.74-1,292.38
Net Financing Active Other Cash Flow-0.35-3.84-8.83-10.12-0.77-21.00-14.92-31.22-46.93
Other Financing Activities Uses-0.35-3.84-8.83-10.12-0.77-21.00-14.92-31.22-46.93
Cash from Financing Activities-863.98-855.05-1,128.23-947.12-661.80-122.5%2,941.66-202.87-235.1%150.13-179.23
Exchange Rate Effect-12.6448.52-26.15-14.05-33.75-22.93-188.5%25.91-0.45-8.00
Net Change in Cash-338.61-243.42-197.3%250.08-43.6%443.63-148.59-168.6%216.72+2.8%210.72+723.8%25.58-36.05
Free Cash Flow590.47506.94-6.4%541.65+5371.2%9.90-98.3%594.18-55.1%1,324.73+62.6%814.67+183.7%287.14+31.8%217.78
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow ratio30.3123.7927.12-31.7218.1520.5342.2646.15
Deferred Taxes & Investment Tax Credit--61.48-102.23-123.66-105.92-55.33-29.12-61.35-51.10

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments593.40-36.4%1,023.66+3.1%860.75-24.4%919.87-21.0%932.58-24.2%992.99-49.2%1,138.69-32.8%1,164.45-27.4%
Short Term Receivables687.33+1.0%709.17+7.3%691.38+12.0%744.67+17.8%680.26+13.0%661.14+10.7%617.42+4.8%632.40-0.1%
Inventories388.85+2.4%378.50-2.6%387.50+1.6%379.50+3.2%379.92-6.1%388.47-3.2%381.31-7.9%367.59-14.1%
Other Current Assets191.81+27.0%186.39-3.7%188.68+4.5%195.71+5.7%151.04-28.7%193.59-5.9%180.53-50.0%185.17-44.9%
Total Current Assets1,861.39-13.2%2,297.72+2.8%2,128.32-8.2%2,239.75-4.7%2,143.79-12.4%2,236.18-29.2%2,317.94-24.2%2,349.61-21.7%
Net Property, Plant & Equipment597.69-10.5%607.20-10.2%628.89-4.8%644.69-0.8%668.17+0.1%676.19+4.5%660.38+1.2%649.93-2.2%
Total Investments and Advances0.570.530.0093.13-3.8%0.000.000.0096.78+13.7%
Intangible Assets8,725.70-3.3%8,831.80-3.3%8,917.28-1.8%8,960.50-1.6%9,026.56-3.2%9,129.36-2.1%9,082.86-3.6%9,104.54-4.7%
Deferred Tax Assets---32.65+482.0%---5.61-31.3%
Other Assets275.39-8.3%276.39-13.9%322.10+7.5%159.69+1.2%300.44-9.6%321.06+8.2%299.55+0.6%157.84-28.3%
Total Assets11,490.35-5.3%12,045.83-2.6%11,996.59-2.9%12,168.41-1.8%12,138.95-4.9%12,362.79-7.9%12,360.72-8.0%12,392.48-8.6%
Short Term Debt Incl. Current Port. of LT Debt0.00-100.0%572.16+248665.2%575.83+239829.2%618.86+2498.1%583.84+56038.5%0.23-100.0%0.24-100.0%23.82-96.8%
Accounts Payable163.27-7.1%165.74-7.0%169.68-4.7%185.46+10.7%175.80-0.3%178.15+1.9%178.09-3.0%167.46-18.0%
Income Tax Payable---80.56+8.3%---74.40-15.6%
Other Current Liabilities538.21+16.2%538.46+9.1%493.13+5.0%446.35+15.2%463.10-9.3%493.43-2.0%469.86-2.0%387.41-4.0%
Total Current Liabilities701.48-42.6%1,276.36+90.0%1,238.64+91.1%1,331.25+103.8%1,222.74+77.7%671.81-51.7%648.19-52.8%653.10-55.0%
Long Term Debt2,765.03-0.7%2,769.36-17.9%2,774.35-16.6%2,779.34-15.8%2,785.16-16.0%3,374.63+2.7%3,325.12+1.0%3,301.98-0.3%
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities---487.25+6.8%---456.10
Other Liabilities752.73-0.3%771.36+1.5%800.86+6.7%320.21+1.8%755.15-10.7%760.18-13.5%750.28-18.4%314.42-66.2%
Total Liabilities4,219.24-11.4%4,817.08+0.2%4,813.85+1.9%4,918.05+4.1%4,763.06-1.8%4,806.62-13.5%4,723.59-15.4%4,725.60-17.0%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity7,271.11-1.4%7,228.76-4.3%7,182.74-5.9%7,250.36-5.4%7,375.90-6.9%7,556.17-4.0%7,637.13-2.7%7,666.87-2.6%
Total Shareholders Equity7,271.11-1.4%7,228.76-4.3%7,182.74-5.9%7,250.36-5.4%7,375.90-6.9%7,556.17-4.0%7,637.13-2.7%7,666.87-2.6%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity7,271.11-1.4%7,228.76-4.3%7,182.74-5.9%7,250.36-5.4%7,375.90-6.9%7,556.17-4.0%7,637.13-2.7%7,666.87-2.6%
Total Liabilities & Stockholders Equity11,490.35-5.3%12,045.83-2.6%11,996.59-2.9%12,168.41-1.8%12,138.95-4.9%12,362.79-7.9%12,360.72-8.0%12,392.48-8.6%
Book Value Per Share per share65.14+0.7%64.78-0.3%64.34+0.6%64.57+1.6%64.68-0.3%64.95+1.8%63.96+0.7%63.55-0.4%
Tangible Book Value Per Share per share-13.03-14.37-15.54-15.23-14.48-13.52-12.11-11.92
Full-Time Employees people---11,0000.0%---11,000-4.3%
Price to Book Ratio ratio2.411.731.361.501.351.511.661.72
Return on Assets %2.141.941.961.951.872.162.302.18
Return on Equity %3.453.213.233.223.043.613.823.64
Return on Invested Capital %0.620.520.410.980.460.500.380.87
Quick Ratio ratio2.101.501.411.401.442.752.993.03
Current Ratio ratio2.651.801.721.681.753.333.583.60

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income62.30+37.7%51.82-8.3%40.72-0.9%98.36+3.9%45.24-52.1%56.50+2.1%41.10+58.0%94.64+20.5%
Depreciation102.92+0.8%102.04-0.7%105.06+7.8%103.08-1.9%102.06-5.2%102.78-4.2%97.42-9.6%105.03-0.5%
Other Funds (Non Cash)37.87+40.7%56.16+135.7%9.18+1632.1%40.91+152.8%26.9123.83+213.6%0.53-98.4%16.18-69.7%
Funds from Operations203.09+16.6%210.02+14.7%154.95+11.4%180.87+59.2%174.21-11.3%183.10+7.5%139.06-16.4%113.62-0.2%
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-36.38-18.08-39.721.09-98.2%-35.71-48.86-13.3060.60-26.8%
Cash from Operating Activities166.70+20.4%191.94+43.0%115.23-8.4%181.96+4.4%138.50-6.3%134.25-15.4%125.75-14.8%174.23-11.4%
Capital Expenditures-14.35-11.07-19.77-20.17-18.50-18.87-15.98-24.45
Net Assets From Acquisitions0.000.22-67.280.000.000.000.000.00
Sale of Fixed Assets and Businesses0.003.049.16+3882.6%0.070.000.000.230.00
Purchase or Sale of Investments-1.253.260.68-0.390.00-100.0%0.000.00-2.25-100.8%
Purchase of Investments-1.25-3.560.00-0.390.000.000.00-2.25-100.3%
Sale Or Maturity of Investments0.006.820.680.000.00-100.0%0.000.000.00
Other Uses0.001.05-1.050.03-0.030.00-100.0%0.000.00
Other Sources0.00-100.0%0.00-100.0%0.00-100.0%0.00-100.0%37.509.38-93.6%9.389.38-98.3%
Cash from Investing Activities-15.60-182.2%-3.50-78.27-20.4518.97-97.3%-9.49-107.8%-6.38-17.33
Cash Dividends Paid-7.81-7.81-7.84-7.96-8.13-8.28-8.43-8.54
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock3.39-15.00-81.06-167.99-205.03-293.91-150.96-183.63
Repurchase of Common Pref Stock-0.10-15.99-86.50-168.28-205.03-293.91-153.59-185.16
Sale of Common Pref Stock3.481.005.44+106.8%0.29-81.0%0.00-100.0%0.00-100.0%2.63-33.2%1.53+146.8%
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-571.190.000.00-0.36-0.06-0.05-0.05-11.59-2566.0%
Change in Long Term Debt-571.190.000.00-0.36-0.06-0.05-0.05-11.59-2566.0%
Issuance of Long Term Debt25.000.000.000.000.000.000.000.00-100.0%
Reduction of Long Term Debt-596.190.000.00-0.36-0.06-0.05-0.05-11.59
Net Financing Active Other Cash Flow0.00-0.350.000.00-100.0%-1.86-631.4%-0.16-1.8210.77
Other Financing Activities Uses0.00-0.350.000.00-100.0%-1.86-631.4%-0.16-1.8210.77
Cash from Financing Activities-575.61-23.16-88.89-176.31-215.07-302.40-161.26-192.99
Exchange Rate Effect-5.71-2.56-108.0%-7.63-147.3%3.26-2.81-116.5%31.9516.12-30.27-312.9%
Net Change in Cash-430.21162.72-59.56-11.54-60.41-145.70-158.3%-25.77-130.3%-66.36
Free Cash Flow152.36+27.0%180.87+56.8%95.45-13.0%161.79+8.0%120.00-4.4%115.38-15.5%109.77-15.4%149.78-13.2%
Price to Free Cash Flow ratio30.3124.1321.6123.1021.0324.6426.0526.90

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Product2,338.212,389.98+2.2%83.7%
Service416.82466.07+11.8%16.3%
Total2,755.032,856.05+3.7%100.0%
Region
Name20242025vs 20242025 share
China450.01425.06-5.5%14.9%
Germany162.58177.66+9.3%6.2%
Other International931.711,000.20+7.4%35.0%
United Kingdom112.88126.85+12.4%4.4%
United States1,097.861,126.27+2.6%39.4%
Total2,755.032,856.05+3.7%100.0%
Segment
Name20242025vs 20242025 share
Diagnostics1,356.431,424.95+5.1%49.9%
Life Sciences1,398.601,431.10+2.3%50.1%
Total2,755.032,856.05+3.7%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.88%6.5M111.1M1.85M
2026-10-155.76%6.4M111.1M1.82M
2026-09-305.67%6.3M111.1M1.72M
2026-09-155.60%6.2M111.1M1.58M
2026-08-315.68%6.3M111.1M1.47M
2026-08-145.78%6.4M111.1M1.49M
2026-07-316.35%7.1M111.0M1.52M
2026-07-156.70%7.4M111.0M1.47M
2026-06-306.88%7.6M111.0M1.42M
2026-06-157.49%8.3M111.0M1.28M
2026-05-297.88%8.7M111.0M1.27M
2026-05-158.58%9.5M111.0M1.19M
2026-04-307.90%8.8M111.3M1.19M
2026-04-157.53%8.4M111.3M1.23M
2026-03-317.41%8.2M111.3M1.34M
2026-03-137.73%8.6M111.3M1.36M
2026-02-277.36%8.2M111.3M1.33M
2026-02-137.15%8.0M111.3M1.52M
2026-01-306.26%7.1M112.9M1.44M
2026-01-156.14%6.9M112.9M1.43M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call85.0070.2073.9081.802.9591.000.000.957-0.3770.021
call90.0065.2069.300.002.6870.000.000.954-0.3720.022
call95.0060.1064.300.002.4680.000.000.950-0.3650.024
call10055.1059.300.002.2600.000.000.945-0.3590.026
call10550.1054.100.002.1780.000.000.940-0.3510.027
call11045.7048.9047.401.9211.000.000.934-0.3420.029
call11540.3044.000.001.7400.000.000.928-0.3330.032
call12035.4039.600.001.5810.000.000.920-0.3220.034
call12530.7034.300.001.4460.000.000.910-0.3100.037
call13026.7028.9031.441.1810.000.000.898-0.2970.041
call13521.4025.2031.291.1941.000.000.883-0.2800.045
call14016.7020.400.001.0840.000.000.783-0.4990.068
call14513.1015.9016.150.9286.000.000.744-0.4560.074
call1509.3012.0012.590.8781640.000.666-0.4800.084
call1556.008.908.900.8491660.000.571-0.4920.090
call1603.606.106.660.8041020.000.463-0.4800.091
call1651.403.903.800.7578710.000.349-0.4090.085
call1701.252.401.200.7372,0411.000.251-0.3490.073
call1750.003.101.750.8786220.000.220-0.3850.068
call1800.003.601.001.0052200.000.199-0.4150.064
call1850.003.900.881.12611.000.000.183-0.4420.061
call1900.003.701.031.2399.000.000.171-0.4640.058
call1950.002.851.971.3492080.000.160-0.4850.056
call2000.004.300.751.4482.000.000.152-0.5020.054
call2100.002.800.001.6380.000.000.139-0.5340.051
put85.000.003.400.002.7670.000.00-0.043-0.3690.021
put90.000.003.400.002.5480.000.00-0.046-0.3620.022
put95.000.003.700.002.3400.000.00-0.050-0.3560.024
put1000.004.900.002.1420.000.00-0.055-0.3480.026
put1050.003.500.701.9513.000.00-0.060-0.3400.027
put1100.003.901.051.7692.000.00-0.066-0.3310.029
put1150.002.250.051.7452.000.00-0.084-0.3920.036
put1200.004.901.501.4212.000.00-0.080-0.3100.034
put1250.004.900.361.2521050.00-0.090-0.2970.037
put1300.001.951.151.0904920.00-0.102-0.2830.041
put1350.001.300.900.9261,1330.00-0.117-0.2660.045
put1400.303.501.331.1295410.00-0.217-0.4830.068
put1451.553.601.650.9441,1060.00-0.256-0.4410.074
put1502.404.802.520.8818340.00-0.334-0.4640.084
put1554.106.504.050.8261670.00-0.431-0.4760.090
put1606.009.107.900.82535.000.00-0.535-0.4630.091
put1659.3011.2010.300.69679.000.00-0.653-0.3920.085
put17013.0015.4011.800.75913.000.00-0.749-0.3310.073
put17517.0020.4013.300.9114.000.00-0.779-0.3660.068
put18021.3025.500.000.9500.000.00-0.801-0.3960.064
put18526.5030.100.001.1080.000.00-0.817-0.4220.061
put19031.2035.200.001.2150.000.00-0.829-0.4440.058
put19536.3040.200.001.3220.000.00-0.840-0.4630.056
put20041.1045.000.001.4230.000.00-0.848-0.4810.054
put21051.3055.000.001.6330.000.00-0.861-0.5110.051

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-10-04SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-10-07SCHEDULE 13G/ASEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-01144Filing for proposed sale of securities under Rule 144.SEC
2026-09-234Statement of changes in beneficial ownership of securities2026-09-21SEC
2026-09-21144Filing for proposed sale of securities under Rule 144.SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-16SEC
2026-09-16144Filing for proposed sale of securities under Rule 144.SEC
2026-09-08SCHEDULE 13G/ASEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-07-05SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-224Statement of changes in beneficial ownership of securities2026-07-20SEC
2026-07-20144Filing for proposed sale of securities under Rule 144.SEC
2026-07-2025-NSESEC
2026-06-2311-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-01SDSpecialized Disclosure ReportSEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-04-05SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100013.06K1
2026-09001.27M2
2026-080000
2026-07009.31K1
2026-060000
2026-050000
2026-04007.42K1
2026-030000
2026-02004.67M5
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
-

Funds

Fund% owned
VANGUARD SHORT-TERM INVESTMENT-GRADE FUND12.25%
Baird Aggregate Bond Fund10.76%
Inspire Corporate Bond ETF10.75%
Baird Core Plus Bond Fund10.55%
VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND10.54%
T. Rowe Price Capital Appreciation Fund10.20%
VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND9.86%
Brown Advisory Sustainable Bond Fund8.47%
VANGUARD INTERMEDIATE-TERM BOND INDEX FUND7.17%
T. Rowe Price New Income Fund, Inc.6.79%

OakChart. RVTY. Cached 15 minutes. Terms